AI drug discovery draws doubts as venture bets yield little and most drugs still fail
Startup Online reports that venture capital bets on AI-based drug development have not paid off so far. Other articles talk of a bubble and ask why nine in ten drugs still fail.
Who is affected and how
- pharmaceuticals
- When investing in AI, companies should ask platform vendors for evidence measured in clinical success rates.
Sources
- Venture investors' bet on AI-based drug development hasn't paid off yet | Startup Onlinestartuponline.hu · Aug 31, 2026 · magyar
- The Naked Emperors of AI Drug Discovery: How Shoemakers Without Shoes Get Attention and Deals and Will the Bubble Burst?forever.ai · Aug 31, 2026
- AI Was Meant To Fix Drug Discovery – So Why Do Nine In Ten Drugs Still Fail? - TechRoundtechround.co.uk · Aug 31, 2026
Machine-generated summary based on the titles and excerpts of the source articles. The source article is the authority for the facts. News monitoring, not medical advice: consult a doctor for health decisions.